STAAR Surgical Company (STAA): A Bull Case Theory
We came across a bullish thesis on STAAR Surgical Company on Yet Another Value Blog’s Substack. In this article, we will summarize the bulls’ thesis on STAA.
Staar Surgical Co (STAA)
Market is closed
Sector: Ophthalmic Goods
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Broadwood Capital Neal C. Bradsher | 15,019,491 | $346,800,047 | +12% | 20.37% |
| 2. | Yunqi Capital Christopher Wang | 2,507,130 | $57,889,632 | +1% | 46.16% |
| 3. | Magnetar Capital Alec Litowitz And Ross Laser | 2,472,390 | $57,087,485 | +106% | 0.56% |
| 4. | Balyasny Asset Management Dmitry Balyasny | 1,541,160 | $35,585,384 | -16% | 0.05% |
| 5. | Alpine Associates Robert Emil Zoellner | 466,607 | $10,773,957 | -49% | 0.72% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 0 | $0.00 | 15,453,629 | 2026-01-09 | Filing | |
| $22.05 | 27,485 | $606,137.70 | 15,453,629 | 2026-01-09 | Filing | |
| $0.00 | 0 | $0.00 | 15,426,144 | 2026-01-08 | Filing | |
| $21.94 | 3,240 | $71,082.04 | 15,426,144 | 2026-01-08 | Filing | |
| $0.00 | 0 | $0.00 | 15,422,904 | 2026-01-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $61.97 | 823 | $51,001.31 | 27,633 | 2023-03-17 | Filing | |
| $75.00 | 13,075 | $980,625.00 | 34,908 | 2022-09-27 | Filing | |
| $75.00 | 15,683 | $1,176,225.00 | 34,908 | 2022-09-27 | Filing | |
| $75.00 | 6,667 | $500,025.00 | 50,591 | 2022-09-27 | Filing | |
| $106.22 | 5,000 | $531,100.00 | 19,437 | 2022-08-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,360,335 | $169,950,136 | 0% | |
| 2. | 4,226,563 | $97,591,340 | 0% | |
| 3. | 2,076,743 | $47,951,996 | 0.01% | |
| 4. | 1,940,439 | $44,804,737 | 0% | |
| 5. | 1,210,667 | $27,959,757 | 0% |
News See All
Analysts Question STAAR Surgical Company (STAA)’s Post-Merger Standalone Valuation
TheFly reported on January 16 that Morgan Stanley resumed coverage of STAA with an Underweight rating and a $13 price target following the termination of its merger agreement with Alcon (ALC).
12 Cheap Small-Cap Stocks to Invest In Before the Next Breakout
As January 2026 progresses, the U.S. stock market is seeing a notable shift, with large-cap dominance, led by the "Magnificent Seven," showing signs of fatigue.
Takeover Agreement with Alcon Sparks Sharp Weekly Gains for STAAR Surgical
California-based company, STAAR Surgical Company (NASDAQ:STAA) develops, manufactures, and markets implantable, foldable Collamer® lenses and delivery systems for cataract and refractive eye surgery.
11 Best Short-Term Stocks to Invest in
The latter half of the 2025 market is caught between conflicting signals.
STAAR Surgical Company (NASDAQ:STAA) Q1 2025 Earnings Call Transcript
Operator: Greetings and welcome to the STAAR Surgical First Quarter 2025 Earnings Webcast. As a reminder, this event is being recorded today Wednesday, May 07, 2025.
STAAR Surgical Company (NASDAQ:STAA) Q4 2024 Earnings Call Transcript
Operator: Greetings and welcome to the STAAR Surgical Fourth Quarter 2024 Earnings Webcast. As a reminder, this event is being recorded today Tuesday, February 11th, 2025.
STAAR Surgical Company (NASDAQ:STAA) Q3 2024 Earnings Call Transcript
Operator: Greetings and welcome to the STAAR Surgical Third Quarter 2024 Earnings Webcast. As a reminder, this event is being recorded today Wednesday, October 30th, 2024.
STAAR Surgical Company (NASDAQ:STAA) Q2 2024 Earnings Call Transcript
Operator: Greetings and welcome to the STAAR Surgical Second Quarter 2024 Earnings Webcast. As a reminder, this event is being recorded today Wednesday, August 7, 2024.
STAAR Surgical Company (NASDAQ:STAA) Q1 2024 Earnings Call Transcript
STAAR Surgical Company misses on earnings expectations. Reported EPS is $-0.06827 EPS, expectations were $0.05.
Hedge Fund Resource Center Billionaire Hedge Funds
